Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Jan. 26, 2015, 32 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $470.00 to $2,120,132.50.

Highlighted Stocks Traded by Insiders:

Main Street Capital Corporation (MAIN) - FREE Research Report

Jackson John Earl, who is Director at Main Street Capital Corporation, bought 34 shares at $28.19 on Jan. 26, 2015. Following this transaction, the Director owned 11,120 shares meaning that the stake was boosted by 0.3% with the 34-share transaction.

Canon Joseph E, who is Director at Main Street Capital Corporation, bought 178 shares at $28.19 on Jan. 26, 2015. Following this transaction, the Director owned 39,974 shares meaning that the stake was boosted by 0.45% with the 178-share transaction.

Magdol David L., who is Chief Invest. Officer and SMD at Main Street Capital Corporation, bought 267 shares at $28.19 on Jan. 26, 2015. Following this transaction, the Chief Invest. Officer and SMD owned 256,518 shares meaning that the stake was boosted by 0.1% with the 267-share transaction.

Hyzak Dwayne L., who is Coo, Smd at Main Street Capital Corporation, bought 326 shares at $28.19 on Jan. 26, 2015. Following this transaction, the Coo, Smd owned 256,616 shares meaning that the stake was boosted by 0.13% with the 326-share transaction.

Hartman Curtis L., who is Chief Credit Officer and SMD at Main Street Capital Corporation, bought 130 shares at $28.19 on Jan. 26, 2015. Following this transaction, the Chief Credit Officer and SMD owned 197,963 shares meaning that the stake was boosted by 0.07% with the 130-share transaction.

Stout Rodger A., who is Evp at Main Street Capital Corporation, bought 104 shares at $28.19 on Jan. 26, 2015. Following this transaction, the Evp owned 145,515 shares meaning that the stake was boosted by 0.07% with the 104-share transaction.

Appling Michael JR, who is Director at Main Street Capital Corporation, bought 533 shares at $28.19 on Jan. 26, 2015. Following this transaction, the Director owned 90,015 shares meaning that the stake was boosted by 0.6% with the 533-share transaction.

Beauvais Jason B, who is SVP, GC, CCO, Sec. at Main Street Capital Corporation, bought 145 shares at $28.19 on Jan. 26, 2015. Following this transaction, the SVP, GC, CCO, Sec. owned 60,698 shares meaning that the stake was boosted by 0.24% with the 145-share transaction.

Smith Brent D., who is CFO, Treasurer at Main Street Capital Corporation, bought 21 shares at $28.19 on Jan. 26, 2015. Following this transaction, the CFO, Treasurer owned 13,526 shares meaning that the stake was boosted by 0.15% with the 21-share transaction.

Griffin Jon Kevin, who is Director at Main Street Capital Corporation, bought 65 shares at $28.19 on Jan. 26, 2015. Following this transaction, the Director owned 12,635 shares meaning that the stake was boosted by 0.51% with the 65-share transaction.

Martin Shannon, who is VP, Chief Accounting Officer at Main Street Capital Corporation, bought 19 shares at $28.19 on Jan. 26, 2015. Following this transaction, the VP, Chief Accounting Officer owned 16,022 shares meaning that the stake was boosted by 0.12% with the 19-share transaction.

The shares most recently traded at $29.45, up $1.26, or 4.28% since the insider transaction. Historical insider transactions for Main Street Capital Corporation go as follows:

  • 4-Week # shares bought: 2,500
  • 12-Week # shares bought: 2,500
  • 24-Week # shares bought: 3,500

The average volume for Main Street Capital Corporation has been 225,800 shares per day over the past 30 days. Main Street Capital Corporation has a market cap of $1.3 billion and is part of the financial sector and financial services industry. Shares are up 0.96% year-to-date as of the close of trading on Monday.

Main Street Capital Corporation is a business development company specializing in long- term equity, equity related, and debt investments in small and lower middle market companies. The stock currently has a dividend yield of 6.96%. The company has a P/E ratio of 13.4. Currently, there are 3 analysts who rate Main Street Capital Corporation a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MAIN - FREE

TheStreet Quant Ratings

rates Main Street Capital Corporation as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth and expanding profit margins. We feel these strengths outweigh the fact that the company has had somewhat weak growth in earnings per share. Get the full

Main Street Capital Corporation Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

MKS Instruments (MKSI) - FREE Research Report

Quirk Brian Charles, who is Sr. VP, Global Operations at MKS Instruments, sold 1,040 shares at $34.76 on Jan. 26, 2015. Following this transaction, the Sr. VP, Global Operations owned 1,042 shares meaning that the stake was reduced by 49.96% with the 1,040-share transaction.

The shares most recently traded at $34.62, down $0.14, or 0.4% since the insider transaction. Historical insider transactions for MKS Instruments go as follows:

  • 4-Week # shares bought: 1,161
  • 4-Week # shares sold: 1,365
  • 12-Week # shares bought: 1,161
  • 12-Week # shares sold: 8,849
  • 24-Week # shares bought: 1,161
  • 24-Week # shares sold: 33,905

The average volume for MKS Instruments has been 273,700 shares per day over the past 30 days. MKS Instruments has a market cap of $1.8 billion and is part of the technology sector and electronics industry. Shares are down 4.29% year-to-date as of the close of trading on Monday.

MKS Instruments, Inc. operates as a provider of instruments, subsystems, and process control solutions that measure, control, power, monitor, and analyze critical parameters of manufacturing processes in the United States and internationally. The stock currently has a dividend yield of 1.9%. The company has a P/E ratio of 18.2. Currently, there are 3 analysts who rate MKS Instruments a buy, 1 analyst rates it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MKSI - FREE

TheStreet Quant Ratings

rates MKS Instruments as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, reasonable valuation levels and compelling growth in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full

MKS Instruments Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Cyberonics (CYBX) - FREE Research Report

Alch Darren, who is VP Genl Counsel Asst Sec at Cyberonics, sold 235 shares at $57.72 on Jan. 26, 2015. Following this transaction, the VP Genl Counsel Asst Sec owned 15,519 shares meaning that the stake was reduced by 1.49% with the 235-share transaction.

The shares most recently traded at $56.91, down $0.81, or 1.42% since the insider transaction. Historical insider transactions for Cyberonics go as follows:

  • 4-Week # shares sold: 4,500
  • 12-Week # shares sold: 19,159
  • 24-Week # shares sold: 35,366

The average volume for Cyberonics has been 398,100 shares per day over the past 30 days. Cyberonics has a market cap of $1.5 billion and is part of the health care sector and health services industry. Shares are up 3.39% year-to-date as of the close of trading on Monday.

Cyberonics, Inc., together with its subsidiaries, designs, develops, markets, and sells implantable medical devices to hospitals and ambulatory surgery centers. The company has a P/E ratio of 24.4. Currently, there are 4 analysts who rate Cyberonics a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CYBX - FREE

TheStreet Quant Ratings

rates Cyberonics as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, expanding profit margins and good cash flow from operations. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full

Cyberonics Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null